Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia

Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease

(2012) María-Jesús Pinazo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Risk of ART Non-Adherence and Delay of ART Initiation among HIV Positive Double Orphans in Kigali, Rwanda

(2012) Kimiyo Kikuchi et al.   PLoS One

Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults

(2010) M.-J. Pinazo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease

(2010) Yves Jackson et al.   CLINICAL INFECTIOUS DISEASES

Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease

(2010) J. Altcheh et al.   PEDIATRICS

An Estimate of the Burden of Chagas Disease in the United States

(2009) Caryn Bern et al.   CLINICAL INFECTIOUS DISEASES

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

(2008) Jose Antonio Marin-Neto et al.   AMERICAN HEART JOURNAL